This inventor holds 1 USPTO granted patent. Top assignee: Reneo Pharmaceuticals, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Niall O′Donnell: Innovator in Pharmaceutical Treatments
Introduction: Niall O′Donnell is a prominent inventor based in San Diego, CA, known for his contributions to the field of pharmaceuticals. With a focus on innovative treatments, he has made significant strides in the development of therapeutic compounds.
Latest Patents: Niall O′Donnell holds a patent for the "Use of PPAR-delta agonists in the treatment of disease." This patent describes the use of sodium (E)-2-(4-((3-(4-fluorophenyl)-3-(4-(3-morpholinoprop-1-yn-1-yl)phenyl)allyl)oxy)-2-methylphenoxy)acetate in the preparation of pharmaceutical compositions aimed at treating diseases or conditions that benefit from PPARδ agonist compounds.
Career Highlights: Throughout his career, Niall has demonstrated a commitment to advancing medical science through innovative research and development. His work has contributed to the understanding and application of PPAR-delta agonists in therapeutic settings.
Collaborations: Niall O′Donnell collaborates with esteemed colleagues, including Lynn Purkins and Alejandro Dorenbaum, at Reneo Pharmaceuticals, Inc. Their combined expertise fosters a dynamic environment for innovation in pharmaceutical research.
Conclusion: Niall O′Donnell's contributions to the field of pharmaceuticals exemplify the impact
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile